Stroke Outcomes Data
Nationally recognized stroke care
In 2013, The Joint Commission designated Thomas Jefferson University Hospital (TJUH) a Comprehensive Stroke Center, the highest designation available.
TJUH also achieved the highest recognition for quality and speed, Get With The Guidelines®‒Stroke Gold Plus Achievement Award with Target: Stroke Honor Roll Elite Plus. The award recognizes 85 percent or higher adherence to quality indicators for two or more years, and measures to increase the speed of administering clot-busting tPA.
Our stroke volume and outcomes data is publicly reported according to Comprehensive Stroke Center requirements. This data reflects stroke admissions to Thomas Jefferson University Hospital & Jefferson Hospital for Neuroscience in Philadelphia. Jefferson Health as a health system admits close to 5,000 stroke patients per year at all hospital locations making us one of the largest health systems in the US treating and caring for strokes.
Thomas Jefferson University Hospital Volumes
|Intracerebral Hemorrhage (ICH)||243||241|
|Subarachnoid Hemorrhage (SAH)||124||117|
Treatment rates for acute ischemic stroke remains low in the United States. Approximately, 3 to 5 percent of all strokes receive treatment utilizing IV Alteplase. Jefferson Health’s average IV Alteplase rate is more than 4 times higher than the national average. Our rate for endovascular treatment utilizing mechanical thrombectomy was 18 percent in 2018.
|Ischemic Stroke Treatment Rate||2017||2018|
|Alteplase (tPA) The Clot Buster||18%||21%|
Endovascular Stroke A-Gram Complication Rate
|Surgical Complication Rate||2017||2018|
|Interventional Neuro-Radiology Complication Rate||0%||0%|